Zhejiang Huahai Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Zhejiang Huahai Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Zhejiang Huahai Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Zhejiang Huahai Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Zhejiang Huahai Pharmaceutical Co Ltd (Huahai Pharmaceuticals) discovers and carries out research, production, and sale of formulations, active pharmaceutical ingredients (APIs), including ACE inhibitors, angiotensin II receptor antagonists, anti-AIDS, anti-depressants, antihistamines, antihypertensives, and antipsychotics, and pharmaceutical intermediates. It also carries out the commercial production of captopril, enalapril, and lisinopril. The company has two reportable segments, Main Business and Other Business. The company operates through subsidiaries in the US and China and distributes its products to several countries worldwide. Huahai Pharmaceuticals is headquartered in Linhai, Zhejiang, China.
Headquarters
China
Address
Zhe Jiang Sheng#xing Lin Hai Shi Xun Qia, Taizhou, Zhejiang, 100000
Website
www.huahaipharm.com
Telephone
86 576 85991096
No of Employees
8,797
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
600521 (SHA)
Revenue (2024)
$1.2B
-10.1%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-76.2%
(2024 vs 2023)
Market Cap*
$3.3B
Net Profit Margin (2024)
XYZ
-73.6%
(2024 vs 2023)
* As of and is in US$
Zhejiang Huahai Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Active Pharmaceutical Ingredients | Technology Services |
| Pharmaceutical Intermediates | Contract Manufacturing Organization (CMO) |
| Formulations: | Import & Export Trade Services |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2022 | Contracts/Agreements | In August, the company and Pfizer signed an agreement for the localized production of the coronavirus treatment drug PAXLOVID. |
| 2022 | Corporate Awards | In May, the company was awarded “Advanced Group” title in the provincial meritorious service competition. |
| 2020 | Contracts/Agreements | In September, the company and Jointown Pharmaceutical Group signed a strategic cooperation to provide domestic patients with high quality medical and health products to improve the national health level. |
Competitor Comparison
| Key Parameters | Zhejiang Huahai Pharmaceutical Co Ltd | Shanghai Pharmaceuticals Holding Co Ltd | Jiangsu Hengrui Pharmaceuticals Co Ltd | CSPC Pharmaceutical Group Ltd | Harbin Pharmaceutical Group Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Taizhou | Shanghai | Lianyungang | Shijiazhuang | Haerbin |
| State/Province | Zhejiang | Shanghai | Jiangsu | Hebei | Heilongjiang |
| No. of Employees | 8,797 | 49,608 | 20,602 | 19,700 | 10,039 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mei Zhang | Chief Financial Officer; Vice President | Senior Management | 2008 | 48 |
| Baohua Chen | Director; President | Executive Board | 2013 | - |
| Zhu Yonghua | Vice President; Director; Secretary | Executive Board | 2009 | - |
| Okabe Kei | President | Senior Management | - | - |
| Kong Xiaofang | Vice President | Senior Management | 2024 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer